Broussonin E could suppress inflammation by modulating macrophages activation state via inhibiting the ERK and p38 MAPK and enhancing JAK2-STAT3 signaling pathway, and can be further developed as a promising drug for the treatment of inflammation-related diseases such as atherosclerosis.
Molecular Weight:
288.34
Purity:
99.86%
CAS Number:
[90902-21-9]
Formula:
C17H20O4
Target:
JAK|||STAT|||ERK|||IL Receptor|||COX|||p38 MAPK
TN3541
TN3541
* VAT and and shipping costs not included. Errors and price changes excepted
